Latest / The Cracking Cancer Podcast
The Challenges with New Cancer Technology. Episode 27.
In this timely episode of "Cracking Cancer," host Dr. Kyle Concannon, a physician scientist, speaks with patient advocate Ashley Holt about the challenges of navigating new, aggressive cancer surveillance technologies. Ashley, a survivor of Stage I non-small cell lung cancer with a ROS1 mutation, chose to go beyond the standard of care by incorporating the Signatera circulating tumor DNA (ctDNA) blood test into her post-lobectomy monitoring.
Ashley shares her intense, real-time experience after her third ctDNA test came back positive despite all her conventional CT scans and a follow-up PET…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.